Jeremy Riva-Cambrin, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy
General Hospital Psychiatry · 2026
Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial
Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2025
Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude
The Canadian Journal of Psychiatry · 2025

All 4 publications

Latest funding

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin
CIHR · 2022 · Co-investigator
$1,000,000

All 1 grants and awards

4 publications.

01

Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy

Doyle Z, Chisamore N, Kaczmarek ES, Johnson DE, Brudner RM, Weiglein G, Blainey MG, Bawks J, Riva-Cambrin J, Sethi R

General Hospital Psychiatry2026

DOI: 10.1016/j.genhosppsych.2026.01.001

02

Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial

Johnson DE, Meshkat S, Kaczmarek ES, Rabin JS, Brudner RM, Chisamore N, Doyle Z, Bawks J, Riva-Cambrin J, Mansur RB

Progress in Neuro-Psychopharmacology and Biological Psychiatry20252 citationsOpen Access

DOI: 10.1016/j.pnpbp.2025.111565

03

Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude

Noah Chisamore, Erica S. Kaczmarek, Zoe Doyle, Danica E. Johnson, Geneva Weiglein, Shakila Meshkat, Ryan M. Brudner, Marc G. Blainey, Jeremy Riva-Cambrin, Roger S. McIntyre, Joshua Daniel Rosenblat

The Canadian Journal of Psychiatry20251 citationsOpen Access

DOI: 10.1177/07067437251328316 PMID: 40129307

04

Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin

Rosenblat JD, Meshkat S, Doyle Z, Kaczmarek E, Brudner RM, Kratiuk K, Mansur RB, Schulz-Quach C, Sethi R, Abate A

Med2024123 citationsOpen Access

DOI: 10.1016/j.medj.2024.01.005

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin

Co-investigatorCIHR2022Op. Gr: Psilocybin-assisted Psychotherapy-Major Depressive Dis./Treat.-Res. Dep.

Principal investigators: Rosenblat, Joshua D; Gallson, Dave; Husain, Muhammad I

Keywords: Clinical Trial; Major Depressive Disorder; Mental Health; Psilocybin-Assisted Therapy; Psychiatry; Psychopharmacology; Psychotherapy; Treatment Resistant Depression

$1,000,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Department of Psychiatry
Psychiatry & Behavioural Neurosciences
Department of Medicine

Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Jordan Bawks

Psychiatry & Behavioural Neurosciences

3 shared papers, latest 2026

Joshua Rosenblat

Department of Psychiatry

3 shared papers, latest 2025

Rodrigo Mansur

Department of Psychiatry

2 shared papers, latest 2025

Roger McIntyre

Department of Psychiatry

2 shared papers, latest 2025

Rickinder Sethi

Department of Psychiatry

2 shared papers, latest 2026

Hilary Offman

Department of Psychiatry

1 shared papers, latest 2024

Fabiano Alves Gomes

Psychiatry & Behavioural Neurosciences

1 shared papers, latest 2024

Christian Schulz-Quach

Department of Psychiatry

1 shared papers, latest 2024

Krista Lanctôt

Department of Psychiatry

1 shared papers, latest 2025

Jennifer Rabin

Department of Medicine

1 shared papers, latest 2025

Amanda Abate

Department of Psychiatry

1 shared papers, latest 2024

Smrita Grewal

Department of Psychiatry

1 shared papers, latest 2024

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Riva-Cambrin, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]